ABSTRACT Under the ongoing COVID-19 prevention and control measures in China, increasing the laboratory severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid testing capacity has become the top priority. Since the COVID-19 outbreak in Xinfadi market in Beijing in June 2020, large-scale screening of key populations has been carried out, challenging the nucleic acid testing capabilities of hospital laboratories. Therefore, within 48 hours, Peking University People’s Hospital (PKUPH) transformed a non-nucleic acid testing laboratory into a SARS-CoV-2 nucleic acid testing laboratory. Based on the original structure of the building, we adapted measures to local conditions, sorted out a new testing process, and quickly started testing for COVID-19. The nucleic acid testing process has been optimized, including quality control, personal operating specifications, and the timeliness of the release of LIS results to form closed-loop management. This high-throughput COVID-19 testing optimization process provides a reference model for other countries that are fighting the epidemic.
【저자키워드】 COVID-19, SARS-CoV-2, nucleic acid testing, testing capacity, PCR laboratory, 【초록키워드】 coronavirus, hospital, Local, Population, Laboratory, China, nucleic acid, COVID-19 testing, COVID-19 outbreak, management, Quality control, university, 48 hours, acute respiratory syndrome, Beijing, measure, SARS-CoV-2 nucleic acid, country, the epidemic, carried, provide, conditions, 【제목키워드】 hospital, COVID-19 epidemic, SARS-CoV-2 nucleic acid, Increasing,